ARMC8 inhibitors belong to a specialized class of chemical compounds designed to modulate the activity of the Armadillo repeat-containing 8 (ARMC8) protein. The ARMC8 protein is a member of the armadillo repeat-containing (ARM) family, characterized by its multiple armadillo repeats, which are 42-amino acid motifs implicated in mediating protein-protein interactions. ARMC8 is involved in diverse cellular processes, including cell cycle regulation, signal transduction, and intracellular transport. Given its role in these fundamental cellular activities, ARMC8 has garnered attention as a target for modulation, leading to the development of specific inhibitors.
The chemical structures of ARMC8 inhibitors are meticulously designed to interact with the active sites or binding pockets of the ARMC8 protein, thereby influencing its function. These inhibitors often exhibit high specificity for ARMC8, minimizing off-target effects on other cellular components. The rational design of these compounds involves a deep understanding of the structural and biochemical features of ARMC8, enabling the creation of molecules that can selectively interfere with its activity. As research in this field progresses, scientists aim to elucidate the precise mechanisms by which ARMC8 inhibitors exert their effects, paving the way for a more comprehensive understanding of cellular processes influenced by ARMC8 and the development of innovative strategies for modulating its function in various biological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-selective kinase inhibitor that can affect a wide range of cell signaling pathways. It may indirectly influence ARMC8 by altering phosphorylation patterns within the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that might indirectly affect ARMC8 function by modulating the PI3K/AKT signaling pathway, which is involved in a broad array of cellular processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and by inhibiting this pathway, it could indirectly modulate the functions associated with ARMC8. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central protein in regulating cell growth and metabolism, potentially affecting ARMC8 indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor with a broader spectrum, which could affect ARMC8 activity indirectly through changes in cellular signaling. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor; by preventing the degradation of proteins, it could alter the cellular environment and indirectly affect ARMC8's function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor similar to Bortezomib and could have similar indirect effects on ARMC8. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which, like U0126, could indirectly affect ARMC8 by altering the MAPK signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, another MAPK pathway component, potentially modifying ARMC8's associated pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, which can affect gene expression broadly and thus might indirectly affect ARMC8. | ||||||